Labcorp introduces a $227 test for pTau217, a form of tau protein linked to amyloid pathology in the brain. A skin biopsy can now diagnose Parkinson's disease by detecting abnormal proteins in nerves, aiding in identifying various related conditions.
ICYMI: A new skin test could be a major breakthrough in diagnosing Parkinson's disease.@domnewlandtv is at CND Life Sciences in Scottsdale with the details. https://t.co/oY0DdmRWD1
Simple Skin Biopsy Accurately Diagnoses Parkinson's Disease and Related Synucleinopathies A novel skin biopsy test can accurately detect alpha-synuclein levels in patients with parkinson’s disease and other conditions. Learn more: https://t.co/nxhTknnQZ3
A skin biopsy to accurately diagnose Parkinson's https://t.co/XLhc2VFdEz @JAMA_current https://t.co/V5W47uQBf3 @betswrites https://t.co/kqPPabdWEG
Scottsdale doctor helps create skin test to help detect diseases like Parkinson’s or dementia https://t.co/LgBtDKyvIq https://t.co/xvdYqbbQ3Q
“Parkinson’s Disease Can Now Be Detected Through the Skin” Article: https://t.co/lI8dawHdMe
Could a skin biopsy diagnose Parkinson disease? Watch this video to learn more then read the JAMA study, “Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies.” https://t.co/rJQauOplDp https://t.co/hwtr4AlBMe
In this study, a high proportion of individuals meeting clinical consensus criteria for Parkinson disease, dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure had phosphorylated α-synuclein detected by skin biopsy. https://t.co/UYSW0LvDkE https://t.co/RtynHSgeE1
Parkinson’s disease can now be diagnosed with a skin biopsy that can detect an abnormal protein people with Parkinson’s have inside their nerves. “The skin test basically is a window into the brain." https://t.co/4Cf3TZwfVO https://t.co/4Cf3TZwfVO
Labcorp expands #Alzheimers blood tests for doctors and drugmakers, with a $227 test for a form of #tau protein (pTau217) that's indicative of #amyloid pathology in the brain and could help identify patents for follow up. More in my story for @endpts https://t.co/DleYQEw3rl